key: cord-1025993-91b04x85 authors: Dzintars, Kathryn; Fabre, Valeria M; Avdic, Edina; Smith, Janessa; Adams-Sommer, Victoria; Townsend, Jennifer; Jenh Hsu, Alice; Cosgrove, Sara E title: Development of an antimicrobial stewardship module in an electronic health record: Options to enhance daily antimicrobial stewardship activities date: 2021-05-27 journal: Am J Health Syst Pharm DOI: 10.1093/ajhp/zxab222 sha: f45969ad0d72de5e43266b07b9e59b1c2c40b47c doc_id: 1025993 cord_uid: 91b04x85 DISCLAIMER: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: The purpose of this manuscript is to describe our experience developing an antimicrobial stewardship (AS) module as a clinical decision support tool in the Epic electronic health record (EHR). SUMMARY: Clinical decision support systems within the EHR can be used to decrease use of broad-spectrum antibiotics, improve antibiotic selection and dosing, decrease adverse effects, reduce antibiotic costs, and reduce the development of antibiotic resistance. The Johns Hopkins Hospital constructed an AS module within Epic. Customized stewardship alerts and scoring systems were developed to triage patients requiring stewardship intervention. This required a multidisciplinary approach with a team comprising AS physicians and pharmacists and Epic information technology personnel, with assistance from clinical microbiology and infection control when necessary. In addition, an intervention database was enhanced with stewardship-specific interventions, and workbench reports were developed specific to AS needs. We herein review the process, advantages, and challenges associated with the development of the Epic AS module. CONCLUSION: Customizing an AS module in an EHR requires significant time and expertise in antimicrobials; however, AS modules have the potential to improve the efficiency of AS personnel in performing daily stewardship activities and reporting through a single system. A c c e p t e d M a n u s c r i p t 4 Antibiotic stewardship programs (ASPs) are dedicated to improving antibiotic use by ensuring that patients who need antibiotics receive the correct agent at the right dose for the optimal duration. ASPs are now required in hospitals by the Joint Commission and by the Centers for Medicare and Medicaid Services. 1,2 A critical component of ASPs, as detailed in the Centers for Disease Control and Prevention (CDC)'s Core Elements of Hospital Antibiotic Stewardship Programs, includes performing daily interventions to optimize antibiotic use. 3 Successful operationalization of this work requires a mechanism to detect patients who are on antibiotics and meet criteria for an intervention. Clinical decision support systems (CDSSs) within electronic health records (EHRs) are tools that can streamline antibiotic interventions by identifying a variety of areas for improvement in antibiotic prescribing. 4, 5 Examples of these include "drug-bug" mismatch, in which the antibiotic that a patient is receiving does not cover the organism identified, and opportunities for deescalation, in which a patient can be switched to a less broad-spectrum antibiotic. Other examples of opportunities for intervention include identification of drug-drug interactions, duplicate antimicrobial coverage (eg, dual anaerobe coverage with piperacillin/tazobactam and metronidazole), and excess duration of therapy. Substantial benefits associated with the use of these systems include decreased use of broad-spectrum antibiotics, improved antibiotic selection and dosing, less frequent adverse effects, reduction in antibiotic costs, reduction in the development of antibiotic resistance, and decreased length of hospitalization. [5] [6] [7] [8] For example, Ghamrawi and colleagues 9 demonstrated that, with CDSSbuilt antimicrobial stewardship (AS) alerts, time to de-escalation was significantly reduced from 28.8 hours to 4.7 hours. Herein, we describe our experience in customizing an AS A c c e p t e d M a n u s c r i p t 5 dashboard in one EHR, from Epic System Corporation (Verona, WI), to facilitate a CDSS for stewardship within the Johns Hopkins Health System (JHHS). 1. Epic is one of the leading providers of EHR systems in the United States, with 28% of the acute care hospital market share in 2018. 10 Entry-level tools available to all Epic users include (1) iVents, an intervention system to record and communicate recommendations; (2) order sets and/or panels; (3) dose-checking decision support, including maximum doses recommended and default dosing weight capabilities; (4) algorithms in the form of navigators that present information in a single location within the EHR to assist with clinical decision-making; (5) patient scoring and monitoring systems; (6) intravenous-to-oral (IV-to-PO) algorithms; (7) and best practice alerts (BPAs), which can be used at the time of ordering to alert providers of potential prescribing problems. 5 Epic released an enhanced version of their EHR in 2014, which included the option to add an infection control (ICON) module for an additional cost. ICON (since renamed Bugsy) features are designed for use by infection preventionists and include days of therapy (DOT) per 1,000 patient-days present calculations for reporting to the National Healthcare Safety Network-Antimicrobial Use and Resistance (NHSN-AUR) module and real-time antibiogram compilation and reporting. 5 Additionally, an AS module was released and has features designed to assist physicians and pharmacists leading stewardship activities. The AS module works in concert with ICON and Willow, the pharmacy medication management system, to allow a multidisciplinary approach to AS practices. The primary feature of the AS module is the AS dashboard, A c c e p t e d M a n u s c r i p t 6 which organizes all AS tools in a single location and includes patient lists, stewardship scoring systems, and stewardship workbench reports. A significant benefit of the dashboard is the inclusion of institution-specific links, which allows providers to access clinical pathways, antibiotic approval policies, hyperlinks to local antibiotic treatment guidelines, antibiotic dosing protocols, and formulary restrictions (for example, Johns Hopkins Hospital Guidelines for Antimicrobial Use [mobile application software]; Cosgrove S, Avdic E, Dzintars K, Fabre M, Bernice F). Epic was implemented at 5 of the 6 hospitals that make up the JHHS. These 5 sites include 2 academic hospitals and 3 community hospitals in the Baltimore and District of Columbia region. All sites have independent ASPs, although there is variation in the resources available to each program, with the academic sites having greater physician and pharmacist full-time equivalents dedicated to AS. Because of the greater resources of the academic sites, the customized AS module was developed by those ASPs. The ASPs desired Epic support for its existing daily interventions of antibiotic preauthorization, prospective audit and feedback, syndrome-related interventions, and real-time review of rapid diagnostic tests and blood culture results; all of these functions required customization in the Epic AS module. The community hospitals adopted the customized module after implementation at the academic hospitals and were given the flexibility to incorporate the rules and interventions that met their needs. For instance, not all rapid diagnostics are available at these sites, so rules related to these components were not included in their workflows. A c c e p t e d M a n u s c r i p t 7 Alerts and patient scoring system. To maximize the potential of the Epic system, the AS team engaged in weekly hour-long telephone calls with Epic information technology (IT) support to build rules for customized alerts and scoring systems in order to prioritize patients in need of stewardship interventions. Table 1 provides a comprehensive list of all standard columns as well as customized alerts with their assigned point value made available at our institutions. Standard columns include a patient's cumulative AMS score as well as a column that generates the change in AMS score over a 24-hour period. These scores comprise values on a scale of 1 to 5 assigned to each rule by the AS team during the build. Once the rule(s) associated with each customizable alert are activated within Epic and are triggered for an individual patient, the standard AS columns will adjust with cumulative scores and score changes. Customizable alerts may have multiple rules associated with them. An example of this would be the "de-escalation of therapy exists" rule. Scenarios at our institution that would trigger this alert include (1) Enterococcus susceptible to ampicillin flagging patients with Enterococcus faecalis in the blood receiving vancomycin or linezolid; growing Gram-positive bacteria when the organism (eg, S. aureus) and/or resistance marker (eg, mecA) are identified by the rapid diagnostic test. Other new rules developed by the AS team are the "restricted antimicrobials overnight" rule to alert pharmacists that orders exist for restricted antimicrobials that are initiated outside of "approval hours" and require approval the following day, as well as the "de-escalation Vanc Zosyn Meropenem greater than 72 hours" rule, a specific rule directing pharmacists to take an "antibiotic time-out" and assess whether ongoing coverage is necessary based on the patient's clinical status and culture results available at that particular point in time. While this rule was developed because documentation of review of the use of vancomycin, piperacillin/tazobactam, and meropenem after 72 hours was a health-system performance metric, similar rules for other antimicrobials can be developed easily. iVent clinical documentation. iVents are Epic tools used to communicate and/or document AS recommendations and interventions within the pharmacy department (Johns Hopkins Hospital Guidelines for Antimicrobial Use). iVents can only be entered by pharmacists, are not visible to nonpharmacist providers, and are not considered part of the medical record unless the documentation is transcribed by the user into a progress note or the "copy and paste" feature is used to enter the iVent as a progress note. Links to iVent entries are also accessible from the AS dashboard. Figure 1 provides an example of iVent documentation in which the rounding pharmacist recommended use of nitrofurantoin in a patient currently on ciprofloxacin for the treatment of cystitis caused by pan-susceptible A c c e p t e d M a n u s c r i p t 9 The AS team developed several iVents to correspond with the customized rules discussed above (Table 2) . AS-specific iVents allow pharmacists to easily document interventions that are specific yet standardized as they review alerts. These iVents populate in the AS dashboard report that can be run in real time and used as a reporting metric for the AS program, including the number and type of interventions made, the time spent, and whether the recommendation was accepted. An example of an AS-specific iVent is "better therapeutic options existed," which contains a series of subtypes to optimally define the intervention being made. In this instance, better therapeutic options include (1) narrowing an agent based on available culture data, (2) need for an alternative agent given prior extensive antibiotic exposure, (3) existence of more effective therapy, (4) patient able to transition from intravenous to oral antibiotics, or (5) current therapy based on a fallacious allergy. An important limitation of iVents is that their use for documentation is limited to pharmacists; other members of the stewardship team (eg, physicians, infection preventionists) do not have access to this function. If data from iVents are used to demonstrate the number and type of stewardship interventions, interventions made by nonpharmacists will not be captured. and final culture results (5 points). While these patients have the same AMS score, the patient with alerts for both a positive blood culture and a restricted antimicrobial should take higher priority for intervention. The AMS score is beneficial to identify patients who require stewardship intervention, but additional evaluation by the AS team is necessary for further stratification. Once a patient row on the dashboard is highlighted, an individual patient AS report appears (bottom box in Figure 2 ) providing information including vital signs and current antibiotic orders as well as a link to "document scoring system review." This is a separate mechanism to document an intervention, provide communication to other team members, or indicate that a particular patient has been reviewed. At our institution, stewardship pharmacists use this to communicate with other pharmacists involved in the care of the same patients (Figure 3 ). This enhancement may prompt more rapid communication between the unit pharmacists and the ASP pharmacist regarding needed changes or may expedite the unit pharmacists' prompting of primary teams to make the necessary changes. Finally, ICON has the ability to calculate DOT per 1,000 patient-days present with the option to automatically submit to the NHSN-AUR module once validation is completed. Information on data validation can be found in the CDC document Antibiotic Use and Resistance Module. 11 Epic uses a proprietary formula that removes patient-level details and transmits data in the format required by the CDC. It is possible to develop a report with these data for internal use without relying only on output from the NHSN-AUR module; however, there are limitations to how these data can be displayed. It is difficult to develop reports assessing and comparing trends over time by unit, service, and antibiotic, and it is not possible to obtain patient-level data to assess which patients contributed to the rates shown. This is particularly a limitation for larger hospitals or health systems with a high number of specialized units. For our health system, we elected to transfer antibiotic use data to a data analytics software platform to develop more useful and actionable antibiotic use dashboards. There are several advantages to having the AS module directly embedded within the health system's chosen EHR. Operationalizing this module within existing software avoids the need for additional contract negotiations with outside vendors as well as the acquisition of financial support for these supplemental programs. Because the program language and logic are the same, there is no requirement to force multiple electronic systems to A c c e p t e d M a n u s c r i p t 13 communicate. The costs that are incurred include the time and efforts of the stewardship team for the build process; however, this is balanced by the improvements in efficiency after implementation. Even though measuring the impact of the AS dashboard is not within the scope of this report, we estimate that this customized AS module allowed us to intervene on 35% more patients and expedite interventions on blood culture results and deescalation of therapy. Several considerations exist before implementing use of the ICON and AS modules. These include identification of all pertinent members of the implementation team; the time commitment of team members to develop, build, and validate customizable alerts, scoring, and reporting; and how the hospital or health system will fund this add-on component to the EHR. Step 1: identify key stewardship priorities. Before starting the build process, it is critical for the AS group to identify all alerts, interventions, and reports that may be useful to their daily workflow and then prioritize these in order of importance. Setting an intervention priority list may require several rounds of review and discussion among the AS group, and it is helpful to set these priorities before meeting with the Epic IT team. We advise creating a broad list of items initially, as it may not be possible for some requests to be built in the dashboard. Step 2: assemble the team. Identification of team members with content expertise in antimicrobials, microbiology, and pharmacy was vital to the successful creation and implementation of our enhanced AS module. Our implementation team comprised AS physicians and pharmacists, as well as several members of the Epic IT team, who we preferred to have backgrounds in either pharmacy or clinical microbiology. Epic IT members A c c e p t e d M a n u s c r i p t 14 with backgrounds in these areas were effectively able to both understand the needs of the AS end users and know how to create the necessary programming in Epic to meet those needs. When necessary, infection control preventionists and members of the microbiology laboratory also took part in the build and validation. Step 3: schedule regular meetings. The time commitment to develop the dashboard is significant. Weekly hour-long telephone calls were scheduled for all members of the implementation team beginning in 2015 and continuing for 18 months before the scheduled Epic go-live on July 1, 2016. During initial telephone calls with Epic IT, the AS priority list was reviewed and we determined what was and was not possible in the build process. Once the list was finalized, the weekly telephone calls followed a stepwise approach, first focusing on rules and alerts, then on iVent types and subtypes, and finally on desired workbench reporting. Step 4: AS dashboard pilot and validation. Once the dashboard is implemented, ensuring alerts are accurately firing and reports are populated with the relevant data is an important aspect of customizing the AS module. Depending on the complexity of the build, there could be numerous alerts that may not be actionable for individual users or hospitals, resulting in risk that clinically important alerts could be lost and an opportunity for an intervention missed. 5, 12 We recommend a trial period to ensure dashboard functionality and to allow for modifications based on observations once the module is implemented. The Nebraska Medical Center reported their experience with the implementation of an electronic CDSS and noted that 76% of the alerts that fired were considered nonactionable; however, others have reported that 40% of the CDDS-AS alerts were actionable. 13 Customization of Epic alerts allows the end user to remove nonactionable alerts from their A c c e p t e d M a n u s c r i p t 15 list and add newly developed alerts. However, we recommend that AS teams reevaluate alerts annually to assess whether they are still value added or no longer relevant. Step 5: customize the process for each hospital site. AS resources vary across hospitals and health systems. In our health system, the academic hospitals moved forward with robust dashboard capabilities with Epic implementation in July 2016, while the community hospitals adopted the customized alerts as more AS human resources became available. For hospitals that wish to enhance the AS module in Epic with limited AS resources, it is advisable to start with 2 to 3 priority interventions and add complexity to the build as the AS team becomes comfortable with the changes. For example, an alert column for an IV-to-PO switch and an alert that triggers once a patient has been on vancomycin for a defined period of time are reasonable initial interventions due to the relative simplicity of the build. These are meaningful interventions that can be tracked and show stewardship impact quickly. Medical centers with established AS programs and/or prior Epic experience can evaluate combinations of alerts, iVents, and workbench reporting to identify what best suits their needs. Health-system-level standardized interventions such as our "Vanc Zosyn Meropenem greater than 72 hours" rule that identified patients who were receiving 1 of these broad-spectrum agents for a minimum of 3 days can be developed to function as a metric to drive AS improvements. Step 6: ongoing validation and upkeep. Continuous surveillance is necessary to ensure that the dashboard continues to function as expected. Validation of data submitted to the NHSN-AUR requires a time commitment from the stewardship team, and additional reports need to be generated in Epic to validate data (eg, calculation of DOTs and days present manually). Antibiogram reporting requires frequent upkeep because bacterial A c c e p t e d M a n u s c r i p t 16 nomenclature and clinical breakpoints for antibiotics often change, leading to the need for updates in Epic and subsequent validation to ensure the reporting is accurate. Finally, the AS team should continuously monitor for institutional changes or new priorities that may require development of new dashboard alerts. For example, a new diagnostics rapid test deployed by the microbiology laboratory will need a new alert so that the AS team can respond rapidly to results and contact the treating provider with recommendations. The Epic AS module can be customized to the needs of individual ASPs to increase the effectiveness and efficiency of AS personnel. While building and implementation are time consuming, in our health system, the time investment was worth the subsequent benefits of a robust AS electronic tracking system. The authors have declared no potential conflicts of interest. A c c e p t e d M a n u s c r i p t M a n u s c r i p t Department of Health and Human Services. Hospital and critical access hospital (CAH) changes to promote innovation, flexibility, and improvement in patient care Centers for Disease Control and Prevention. Core Elements of Hospital Antimicrobial Stewardship Programs Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Use of electronic health records and clinical decision support systems for antimicrobial stewardship The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay Evaluation of antimicrobial stewardshiprelated alerts using a clinical decision support system Epic and Cerner triumph yet again. HealthLeaders Antibiotic Use and Resistance Module. National Healthcare Safety Network; 2021 The "epic" challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology Implementation of a clinical decision support system for antimicrobial stewardship A c c e p t e d M a n u s c r i p t